Lombard Odier Asset Management (Europe) Ltd - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Europe) Ltd ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$345,000
+9.9%
130,0000.0%0.03%
+22.7%
Q3 2014$314,000
-29.1%
130,000
-56.7%
0.02%
-8.3%
Q4 2013$443,000300,0000.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$6,773,0006.36%
SILVERBACK ASSET MANAGEMENT LLC 19,709,000$47,671,0005.58%
Sage Capital Management, LLC 1,660,000$4,009,0003.83%
SYMPHONY ASSET MANAGEMENT LLC 15,190,000$36,741,0003.79%
BASSO CAPITAL MANAGEMENT, L.P. 8,187,000$19,782,0003.03%
CAMDEN ASSET MANAGEMENT L P /CA 29,798,000$72,074,0003.00%
Wellesley Asset Management 15,250$36,969,0002.29%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$20,801,0002.12%
BNP PARIBAS FINANCIAL MARKETS 7,500,000$1,814,100,096,0001.58%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$75,372,0001.57%
View complete list of SALIX PHARMACEUTICALS INC shareholders